Amdocs Ltd
XMUN:AOS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Amdocs Ltd
XMUN:AOS
|
US |
|
Neuropace Inc
NASDAQ:NPCE
|
US |
|
Context Therapeutics Inc
F:6K9
|
US |
|
Steven Madden Ltd
F:SJM
|
US |
|
J
|
Jervois Global Ltd
F:IHS
|
AU |
|
L
|
Labat Africa Ltd
JSE:LAB
|
ZA |
|
G
|
Gibraltar Industries Inc
XMUN:GI2
|
US |
|
T
|
Teck Resources Ltd
F:TPT
|
CA |
|
8
|
888 Holdings PLC
OTC:EIHDF
|
GI |
|
F
|
First Hydrogen Corp
OTC:FHYDF
|
CA |
|
Kirin Holdings Co Ltd
F:KIR
|
JP |
|
C
|
CASH Financial Services Group Ltd
F:CFN0
|
HK |
|
T
|
Take-Two Interactive Software Inc
F:TKE
|
US |
|
G
|
George Weston Ltd
OTC:WNGRF
|
CA |
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
US |
|
C
|
Cidara Therapeutics Inc
F:20D
|
US |
|
Antares Vision SpA
F:2YK
|
IT |
Wall St Price Targets
AOS Price Targets Summary
Amdocs Ltd
According to Wall Street analysts, the average 1-year price target for AOS is 81.95 EUR with a low forecast of 63.13 EUR and a high forecast of 97.28 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AOS's stock price target?
Price Target
81.95
EUR
According to Wall Street analysts, the average 1-year price target for AOS is 81.95 EUR with a low forecast of 63.13 EUR and a high forecast of 97.28 EUR.
What is the Revenue forecast for Amdocs Ltd?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 7 years is 4%.
What is the Operating Income forecast for Amdocs Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Amdocs Ltd?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 5 years is 16%.
